GGrantIndex
← Leaderboards

Linda Ruth Peterson

Washington University

$2,100,314
Attributed
$4,679,261
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $803.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,679,261 · 10

By mechanism

R33$2,186,803 · 1
R61$803,813 · 1
R01$717,452 · 1
R34$700,875 · 1
R21$235,907 · 1
M01$24,911 · 4

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Affect

Research focus

AffectHeart FailureFuturePhysiciansPlasmaCardiovascular SystemRandomizedCardiacPathway InteractionsClinical TrialsPumpMortalityHeartFunctional DisorderResearch DesignPerformancePrimary EndpointCardiovascular DiseasesGrantMeasurementAerobicExerciseActivities Of Daily LivingEvent

Grant awards (17)

The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial$708,812
R33 · FY2025 · HL · contact PI
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial$740,803
R33 · FY2024 · HL · contact PI
The Society of Heart and Vascular Metabolism (SHVM) 21st annual session: Interorgan Crosstalk in Heart and Vascular Metabolism$9,500
R13 · FY2024 · HL · contact PI
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial$737,188
R33 · FY2023 · HL · contact PI
The Inorganic Nitrate and eXercise performance in Heart Failure (iNIX-HF): - a phase II clinical trial$803,813
R61 · FY2022 · HL · contact PI
PREDICTION OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): A NEW PLASMA BIOMARKER$118,125
R21 · FY2020 · HL · contact PI
THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL$229,250
R34 · FY2019 · HL · contact PI
PREDICTION OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): A NEW PLASMA BIOMARKER$117,782
R21 · FY2019 · HL · contact PI
THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL$234,106
R34 · FY2018 · HL · contact PI
THE INORGANIC NITRATE FOR EXERCISE IN HEART FAILURE (INIX-HF) TRIAL$237,519
R34 · FY2017 · HL · contact PI
Altered Myocardial Fatty Acid Metabolism in Obesity$717,452
R01 · FY2007 · HL · contact PI
GASTRIC BYPASS EFFECTS ON MYOCARDIAL METABOLISM$3,931
M01 · FY2007 · RR · contact PI
GASTRIC BYPASS EFFECTS ON MYOCARDIAL METABOLISM$7,497
M01 · FY2006 · RR · contact PI
OBESITY'S EFFECT ON MYOCARDIAL METABOLISM AND IT'S REGULATION$1,666
M01 · FY2006 · RR · contact PI
OBESITY'S EFFECT ON MYOCARDIAL METABOLISM AND IT'S REGULATION$2,875
M01 · FY2005 · RR
Obesity's Effect on Myocardial Metabolism and It's Regulation.$7,026
M01 · FY2004 · RR
Obesity's Effect on Atrial Tissue and Heart Failure$1,916
M01 · FY2004 · RR